3.8 Article

Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous US

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Substance Abuse

Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program

Robert Harris et al.

Summary: This study describes the transition of a mobile street medicine program in Baltimore to telemedicine for buprenorphine treatment during the COVID-19 pandemic and evaluates the one-year treatment retention. The results show that 80.7% of patients remained engaged in treatment at one year, indicating the success of the transition to telemedicine.

DRUG AND ALCOHOL DEPENDENCE (2022)

Letter Health Care Sciences & Services

Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19

Elizabeth A. Samuels et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Letter Medicine, General & Internal

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage

Benjamin A. Barsky et al.

JAMA NETWORK OPEN (2022)

Article Substance Abuse

Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial

Li-Tzy Wu et al.

Summary: The study examined the feasibility and acceptability of pharmacy administration and dispensing of methadone for methadone maintenance treatment. The results showed that this model is feasible and satisfactory to patients.

ADDICTION (2022)

Article Economics

Disparities in Access to Radiation Therapy by Race and Ethnicity in the United States With Focus on American Indian/Alaska Native People

Solmaz Amiri et al.

Summary: This study analyzed the disparities in access to radiation therapy (RT) among racial and ethnic-minority patients. The results showed that patients in AI/AN-majority block groups had longer travel distances to the nearest RT facility compared to block groups with non-AI/AN majorities. Additionally, patients in more deprived areas and in micropolitan, small town, and rural areas also experienced longer travel distances.

VALUE IN HEALTH (2022)

Article Medicine, General & Internal

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic

Thuy Nguyen et al.

Summary: This study found that the COVID-19 pandemic resulted in a decrease in filled buprenorphine prescriptions for members of racial and ethnic minority groups, but not for White individuals. These findings suggest that members of racial and ethnic minority groups experienced greater loss in access to buprenorphine during the pandemic across different payer types.

JAMA NETWORK OPEN (2022)

Article Medicine, General & Internal

Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic

Madeline C. Frost et al.

Summary: The study found that many patients accessed buprenorphine via telephone, and some were less likely to have any video visits. The results suggest that discontinuing or reducing telephone access may disrupt treatment for many patients, particularly groups with access disparities such as Black patients and those experiencing homelessness.

JAMA NETWORK OPEN (2022)

Article Economics

Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis

Solmaz Amiri et al.

Summary: The study aimed to measure access to opioid treatment programs and office-based buprenorphine treatment in the United States, revealing disparities in access across urban-rural and area deprivation continua. Results showed differences in access to treatment, particularly in more deprived small towns and micropolitan areas.

VALUE IN HEALTH (2021)

Article Health Care Sciences & Services

Policy Responses to the Addiction Crisis

Richard G. Frank et al.

Summary: The new Biden administration will face two public health crises - the COVID-19 pandemic and the addiction crisis. The opioid epidemic, part of the broader population health challenge, has already caused more American deaths than World Wars I and II combined. By improving treatment services and reducing population exposure to addictive substances, evidence-based policies can save thousands of lives every year.

JOURNAL OF HEALTH POLITICS POLICY AND LAW (2021)

Article Substance Abuse

Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment

Solmaz Amiri et al.

Summary: This study compared the drive time to the nearest opioid treatment program and office-based buprenorphine treatment across urban-rural continuum in the U.S. The results showed that the mean travel time to the closest OBBT was significantly smaller than the mean travel time to the closest OTP, and some areas had heavy travel burden.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Health Care Sciences & Services

Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder

Barbara Andraka-Christou

Summary: Despite the higher rate of opioid-related deaths among people of color compared to non-Hispanic White people, there is a disproportionately low initiation and retention of medication treatment for OUD among people of color. Methadone, a stigmatized and burdensome treatment option, is the predominant medication used for OUD in this population. To address these disparities, policymakers should consider strategies such as Medicaid expansion, increased funding, retention of telehealth policies, and regulatory changes.

HEALTH AFFAIRS (2021)

Article Substance Abuse

Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report

Paul J. Joudrey et al.

Summary: In the United States, there are issues of shortage and inequities in access to methadone treatment for opioid use disorder (OUD), prompting the establishment of a research agenda by the National Institute on Drug Abuse. The research agenda focuses on expanding access to methadone treatment through various mechanisms, including exploring the impact of different treatment structures and medications, investigating optimal support structures for medical providers, and assessing the benefits and risks of expanded methadone access. Additionally, the agenda addresses important cross-cutting issues such as patient characteristics, treatment system features, and methods of measuring outcomes, shaping a comprehensive plan to improve access to methadone in the US.

SUBSTANCE ABUSE (2021)

Editorial Material Health Policy & Services

Private Coverage of Methadone in Outpatient Treatment Programs

Daniel Polsky et al.

PSYCHIATRIC SERVICES (2020)

Article Clinical Neurology

Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume

Jack F. Hunt et al.

JAMA NEUROLOGY (2020)

Article Health Care Sciences & Services

Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework

Ju Nyeong Park et al.

MILBANK QUARTERLY (2020)

Article Primary Health Care

Barriers, Facilitators, and Suggested Interventions for Lung Cancer Screening Among a Rural Screening-Eligible Population

Jenna E. Schiffelbein et al.

JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2020)

Article Oncology

American Indian Women Cancer Survivor's Needs and Preferences: Community Support for Cancer Experiences

Catherine E. Burnette et al.

JOURNAL OF CANCER EDUCATION (2019)

Article Health Care Sciences & Services

Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction

S. L. Calcaterra et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2019)

Letter Psychiatry

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

Pooja A. Lagisetty et al.

JAMA PSYCHIATRY (2019)

Article Psychology

Increasing Access to Opioid Use Disorder Treatment: Assessing State Policies and the Evidence Behind Them

Jesse M. Hinde et al.

Journal of Studies on Alcohol and Drugs (2019)

Article Medicine, General & Internal

Race/Ethnicity and Geographic Access to Urban Trauma Care

Elizabeth L. Tung et al.

JAMA NETWORK OPEN (2019)

Article Public, Environmental & Occupational Health

Community pharmacies as access points for addiction treatment

Kevin A. Look et al.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2019)

Editorial Material Medicine, General & Internal

Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment

Jeffrey H. Samet et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Editorial Material Medicine, General & Internal

Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids

Suzanne Nielsen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Public, Environmental & Occupational Health

Disparities in cancer screening by occupational characteristics

Stacey A. Fedewa et al.

PREVENTIVE MEDICINE (2017)

Article Multidisciplinary Sciences

The availability of pharmacies in the United States: 2007-2015

Dima Mazen Qato et al.

PLOS ONE (2017)

Review Public, Environmental & Occupational Health

Hispanic health in the USA: a scoping review of the literature

Eduardo Velasco-Mondragon et al.

PUBLIC HEALTH REVIEWS (2016)

Article Public, Environmental & Occupational Health

American Indian Health Policy: Historical Trends and Contemporary Issues

Donald Warne et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2014)

Article Public, Environmental & Occupational Health

Disparities in Cancer Mortality and Incidence Among American Indians and Alaska Natives in the United States

Mary C. White et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2014)

Article Health Care Sciences & Services

Black Patients More Likely Than Whites To Undergo Surgery At Low-Quality Hospitals In Segregated Regions

Justin Dimick et al.

HEALTH AFFAIRS (2013)

Article Health Care Sciences & Services

Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York City

Helena B. Hansen et al.

JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2013)

Article Psychology, Clinical

Racism and Health I: Pathways and Scientific Evidence

David R. Williams et al.

AMERICAN BEHAVIORAL SCIENTIST (2013)

News Item Medicine, General & Internal

The redlining of harm reduction programs

Paul Christopher Webster

CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)

Article Health Care Sciences & Services

Geographic Access to Hospice in the United States

Melissa D. A. Carlson et al.

JOURNAL OF PALLIATIVE MEDICINE (2010)

Article Oncology

Geographic access to cancer care in the U.S

Tracy Onega et al.

CANCER (2008)

Article Substance Abuse

Safety, Efficacy, and Feasibility of Office-based Prescribing and Community Pharmacy Dispensing of Methadone

Ellen Tuchman et al.

ADDICTIVE DISORDERS & THEIR TREATMENT (2006)

Review Primary Health Care

Potential barriers to the use of health services among ethnic minorities: a review

Emmanuel Scheppers et al.

FAMILY PRACTICE (2006)

Article Health Care Sciences & Services

Methadone medical maintenance in primary care - An implementation evaluation

JO Merrill et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2005)

Article Public, Environmental & Occupational Health

Area deprivation and widening inequalities in US mortality, 1969-1998

GK Singh

AMERICAN JOURNAL OF PUBLIC HEALTH (2003)

Article Medicine, General & Internal

Methadone maintenance in primary care - A randomized controlled trial

DA Fiellin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)